Takotsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: Institutional experience and literature review
Highlights • TCM increases the mortality rate of SAH. • The use of vasopressors in TCM to treat vasospasm is not contraindicated and was associated with overall better outcome in our patient population. • The use of beta blockers was not associated with significant difference in outcome in our patie...
Gespeichert in:
Veröffentlicht in: | Clinical neurology and neurosurgery 2016-02, Vol.141, p.65-70 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • TCM increases the mortality rate of SAH. • The use of vasopressors in TCM to treat vasospasm is not contraindicated and was associated with overall better outcome in our patient population. • The use of beta blockers was not associated with significant difference in outcome in our patients. • Anesthesia and surgical clipping of aneurysms is safe in patients with TCM and SAH. • Swan Ganz catheter has a limited use in monitoring patients with TCM. |
---|---|
ISSN: | 0303-8467 1872-6968 |
DOI: | 10.1016/j.clineuro.2015.12.005 |